Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited)

v3.21.2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 2 $ 126,626 $ (42,172) $ 84,456
Balance (in Shares) at Dec. 31, 2019 22,862,835      
Exercise of stock options [1] 106 106
Exercise of stock options (in Shares) 57,325      
Stock-based compensation expenses 337 337
Net loss (5,901) (5,901)
Balance at Mar. 31, 2020 $ 2 127,069 (48,073) 78,998
Balance (in Shares) at Mar. 31, 2020 22,920,160      
Exercise of stock options [1] 52 52
Exercise of stock options (in Shares) 220,104      
Stock-based compensation expenses 677 677
Net loss (6,206) (6,206)
Balance at Jun. 30, 2020 $ 2 127,798 (54,279) 73,521
Balance (in Shares) at Jun. 30, 2020 23,140,264      
Balance at Dec. 31, 2020 $ 2 129,725 (72,258) 57,469
Balance (in Shares) at Dec. 31, 2020 23,264,637      
Exercise of stock options [1] 23 23
Exercise of stock options (in Shares) 12,646      
Exercise of warrants (**) [2] [1]
Exercise of warrants (**) (in Shares) [2] 362,383      
Issuance of Common Stock under Open Market Sales Agreement [1] 4,334 4,334
Issuance of Common Stock under Open Market Sales Agreement (in Shares) 601,674      
Stock-based compensation expenses 530 530
Net loss (8,402) (8,402)
Balance at Mar. 31, 2021 $ 2 134,612 (80,660) 53,954
Balance (in Shares) at Mar. 31, 2021 24,241,340      
Exercise of stock options [1] 78   78
Exercise of stock options (in Shares) 55,246      
Issuance of Common Stock under Open Market Sales Agreement [1] 801   801
Issuance of Common Stock under Open Market Sales Agreement (in Shares) 132,490      
Stock-based compensation expenses   1,095   1,095
Net loss     (7,336) (7,336)
Balance at Jun. 30, 2021 $ 2 $ 136,586 $ (87,996) $ 48,592
Balance (in Shares) at Jun. 30, 2021 24,429,076      
[1] Less than $1.
[2] See Note 5B.